Fertility Preservation in Men Affected by Cancer

Completed

• Conditions: Cancer

• Registration Number: NCT03876366
• Lead Sponsor: University Hospital, Basel, Switzerland

Brief Summary

This is a single center cross-sectional retrospective study with a quantitative and qualitative approach (phase 1 and 2). In phase 1 an online survey will be realized and targets male cancer survivors. Phase 2 will take a qualitative approach, in which information about patient's experiences, needs and helpful support will be collected by establishing focus groups of cancer patients who had been diagnosed during the reproductive age.

In the end, the results of this study will be integrated into the development of an online support tool concerning Fertility Preservation (FP).

Detailed Description

Not available

Study Timeline

• Study Start: 2018-01-02
• Study First Submitted: 2019-02-26
• Study First Submitted QC: 2019-03-12
• Study First Posted: 2019-03-15
• Primary Completion: 2020-02-13
• Study Completion: 2020-02-13
• Status Verified: 2020-03
• Last Update Submitted: 2020-03-24
• Last Update Posted: 2020-03-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 71

Inclusion Criteria

• German speaking
• Cancer diagnosis within the last 10 years (minimum age at diagnosis 13 years)
• Cancer therapy that was expected to impair fertility

Exclusion Criteria

• Prepubertal at diagnosis

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
male cancer patients level of information with regard to FP	Phase 2 focus group meeting (approx. 2 to 4 weeks after baseline)	Phase 2: interview (strictly exploratory) in focus groups collecting data on male cancer patients level of information with regard to FP

Secondary Outcome Measures

Name	Time	Method
male cancer patients needs regarding decision-making about FP	Phase 2 focus group meeting (approx. 2 to 4 weeks after baseline)	Phase 2: interview (strictly exploratory) in focus groups evaluating which kind of support regarding decision-making about FP male cancer patients consider helpful
male cancer patients expectation with regard to an online DA tool about FP	Phase 2 focus group meeting (approx. 2 to 4 weeks after baseline)	Phase 2: interview (strictly exploratory) in focus groups evaluating how an online DA tool about FP has to be designed in order to be helpful for male cancer patients

Trial Locations

Locations (1)

Frauenklinik University Hospital Basel; 🇨🇭 Basel, Switzerland